Page 1 of Clinical Trials for stage II study, 23981 Total Matches
- 1CompletedLast Updated: March 8, 2012Condition(s): Drug Abuse
- 2Active, not recruitingLast Updated: October 26, 2011Condition(s): Sleep Apnea, Obstructive
- 3RecruitingLast Updated: December 22, 2010Condition(s): Adolescent Substance Use
- 4CompletedLast Updated: June 29, 2009Condition(s): Non Small Cell Lung Carcinoma
- 5CompletedLast Updated: July 28, 2010Condition(s): Lung Neoplasm; Carcinoma, Bronchogenic
- 6WithdrawnLast Updated: June 6, 2011Condition(s): Solid Tumors Stage II, Stage III and Stage IV; Breast Cancer; Colorectal Cancer; Prostate Cancer; Melanoma; Ovarian Cancer; Sarcoma; Non-small Cell Lung Cancer
- 7CompletedLast Updated: January 1, 2012Condition(s): Breast Cancer
- 8WithdrawnLast Updated: March 22, 2012Condition(s): Cancer
- 9RecruitingLast Updated: January 3, 2012Condition(s): HER2-positive Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer
- 10RecruitingLast Updated: March 9, 2011Condition(s): Rectal Cancer Stage II; Rectal Cancer Stage III
- 11Active, not recruitingLast Updated: July 13, 2011Condition(s): Breast Cancer
- 12RecruitingLast Updated: July 1, 2009Condition(s): Lymphoma
- 13TerminatedLast Updated: November 23, 2009Condition(s): Colorectal Cancer
- 14Active, not recruitingLast Updated: July 19, 2011Condition(s): Breast Cancer
- 15Active, not recruitingLast Updated: February 17, 2010Condition(s): Lymphoma
- 16RecruitingLast Updated: April 27, 2012Condition(s): Non-small Cell Lung Cancer Stage II; Non-small Cell Lung Cancer Stage IIIA; Epithelial Growth Factor Receptor Positive Non-small Cell Lung Cancer
- 17CompletedLast Updated: February 6, 2009Condition(s): Colorectal Cancer
- 18RecruitingLast Updated: October 27, 2011Condition(s): Pancreatic Cancer Stage II; Pancreatic Cancer Stage III
- 19Active, not recruitingLast Updated: March 22, 2012Condition(s): Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Waldenström Macroglobulinemia
- 20CompletedLast Updated: October 28, 2011Condition(s): Esophageal Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=stage+II+study
